We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OPDP Untitled Letter Hits Hospira Over YouTube Promo
OPDP Untitled Letter Hits Hospira Over YouTube Promo
The FDA’s chief watchdog for drug promotion — the Office of Prescription Drug Promotion — issued its first untitled letter of the year, blasting Hospira for running an online video that omitted multiple required disclosures.